Figure 3
From: The impact of Cysteine-Rich Intestinal Protein 1 (CRIP1) in human breast cancer
CRIP1 protein levels in breast cancer cell lines and after transient downregulation in T47D cells. (A) Western blot analysis of HER2 and CRIP1 expression in seven breast cancer cell lines using antibodies targeting HER2, CRIP1 and tubulin (loading control). (B) Western blot analysis of CRIP1 expression in nontransfected T47D cells (mock) and transiently transfected T47D cells using four different siRNAs and siRNAGAPDH (positive control).